E-drug: Isomers and omeprazole (cont'd)
----------------------------------------------------
On Kirsten Myhr's message:
Astra is developing a tablet formulation which it will only
register in high-cost countries (Nordic countries, UK, France,
Germany, Austria and Switzerland) i.e. not in Southern
Europe. Then it will withdraw the capsules in this market.
This is probably to prevent the parallel import taking place
today. The parallel imported drugs most often come from
Greece, Italy, Spain and Portugal.
The tablets arrived in Canada some time ago. Has anyone
seen post-marketing reports of any change in effectiveness
(compared to the capsule formulation)?
Randy Trinkle, BScPharm, BA
Clinical Pharmacist
Cross Cancer Institute
Edmonton, AB
e-mail:rtrinkle@datanet.ab.ca
Health Science links:
http://www.datanet.ab.ca/users/rtrinkle
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.